Madelyn A. Gillentine,Tianyun Wang,Kendra Hoekzema,Jill Rosenfeld,Pengfei Liu,Hui Guo,Chang N. Kim,Bert B. A. De Vries,Lisenka E. L. M. Vissers,Magnus Nordenskjold,Malin Kvarnung,Anna Lindstrand,Ann Nordgren,Jozef Gecz,Maria Iascone,Anna Cereda,Agnese Scatigno,Silvia Maitz,Ginevra Zanni,Enrico Bertini,Christiane Zweier,Sarah Schuhmann,Antje Wiesener,Micah Pepper,Heena Panjwani,Erin Torti,Farida Abid,Irina Anselm,Siddharth Srivastava,Paldeep Atwal,Carlos A. Bacino,Gifty Bhat,Katherine Cobian,Lynne M. Bird,Jennifer Friedman,Meredith S. Wright,Bert Callewaert,Florence Petit,Sophie Mathieu,Alexandra Afenjar,Celenie K. Christensen,Kerry M. White,Orly Elpeleg,Itai Berger,Edward J. Espineli,Christina Fagerberg,Charlotte Brasch-Andersen,Lars Kjærsgaard Hansen,Timothy Feyma,Susan Hughes,Isabelle Thiffault,Bonnie Sullivan,Shuang Yan,Kory Keller,Boris Keren,Cyril Mignot,Frank Kooy,Marije Meuwissen,Alice Basinger,Mary Kukolich,Meredith Philips,Lucia Ortega,Margaret Drummond-Borg,Mathilde Lauridsen,Kristina Sorensen,Anna Lehman,Elena Lopez-Rangel,Paul Levy,Davor Lessel,Timothy Lotze,Suneeta Madan-Khetarpal,Jessica Sebastian,Jodie Vento,Divya Vats,L. Manace Benman,Shane Mckee,Ghayda M. Mirzaa,Candace Muss,John Pappas,Hilde Peeters,Corrado Romano,Maurizio Elia,Ornella Galesi,Marleen E. H. Simon,Koen L. I. van Gassen,Kara Simpson,Robert Stratton,Sabeen Syed,Julien Thevenon,Irene Valenzuela Palafoll,Antonio Vitobello,Marie Bournez,Laurence Faivre,Kun Xia,John Acampado,Rachel K. Earl,Tomasz Nowakowski,Raphael A. Bernier,Evan E. Eichler

Abstract:Background With the increasing number of genomic sequencing studies, hundreds of genes have been implicated in neurodevelopmental disorders (NDDs). The rate of gene discovery far outpaces our understanding of genotype–phenotype correlations, with clinical characterization remaining a bottleneck for understanding NDDs. Most disease-associated Mendelian genes are members of gene families, and we hypothesize that those with related molecular function share clinical presentations. Methods We tested our hypothesis by considering gene families that have multiple members with an enrichment of de novo variants among NDDs, as determined by previous meta-analyses. One of these gene families is the heterogeneous nuclear ribonucleoproteins (hnRNPs), which has 33 members, five of which have been recently identified as NDD genes ( HNRNPK , HNRNPU , HNRNPH1 , HNRNPH2 , and HNRNPR ) and two of which have significant enrichment in our previous meta-analysis of probands with NDDs ( HNRNPU and SYNCRIP ). Utilizing protein homology, mutation analyses, gene expression analyses, and phenotypic characterization, we provide evidence for variation in 12 HNRNP genes as candidates for NDDs. Seven are potentially novel while the remaining genes in the family likely do not significantly contribute to NDD risk. Results We report 119 new NDD cases (64 de novo variants) through sequencing and international collaborations and combined with published clinical case reports. We consider 235 cases with gene-disruptive single-nucleotide variants or indels and 15 cases with small copy number variants. Three hnRNP-encoding genes reach nominal or exome-wide significance for de novo variant enrichment, while nine are candidates for pathogenic mutations. Comparison of HNRNP gene expression shows a pattern consistent with a role in cerebral cortical development with enriched expression among radial glial progenitors. Clinical assessment of probands ( n = 188–221) expands the phenotypes associated with HNRNP rare variants, and phenotypes associated with variation in the HNRNP genes distinguishes them as a subgroup of NDDs. Conclusions Overall, our novel approach of exploiting gene families in NDDs identifies new HNRNP -related disorders, expands the phenotypes of known HNRNP -related disorders, strongly implicates disruption of the hnRNPs as a whole in NDDs, and supports that NDD subtypes likely have shared molecular pathogenesis. To date, this is the first study to identify novel genetic disorders based on the presence of disorders in related genes. We also perform the first phenotypic analyses focusing on related genes. Finally, we show that radial glial expression of these genes is likely critical during neurodevelopment. This is important for diagnostics, as well as developing strategies to best study these genes for the development of therapeutics.

Scaled and Efficient Derivation of Loss of Function Alleles in Risk Genes for Neurodevelopmental and Psychiatric Disorders in Human iPSC

Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs

CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency

A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing

KOLF2.1J iPSCs carry CNVs associated with neurodevelopmental disorders

A de novo Missense Mutation in PPP2R5D Alters Dopamine Pathways and Morphology of iPSC-derived Midbrain Neurons

Functional characterization of gene regulatory elements and neuropsychiatric disease-associated risk loci in iPSCs and iPSC-derived neurons

A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation

Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model

Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium

CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment

Human 8-Cell Embryos Enable Efficient Induction of Disease-Preventive Mutations Without Off-Target Effect by Cytosine Base Editor

Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants

Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders

Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing

Genome-wide prediction of dominant and recessive neurodevelopmental disorder risk genes

CRISPR tiling deletion screens reveal functional enhancers of neuropsychiatric risk genes and allelic compensation effects (ACE) on transcription

High-throughput single-cell functional elucidation of neurodevelopmental disease-associated genes reveals convergent mechanisms altering neuronal differentiation

CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells

Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases

Spliceosome malfunction causes neurodevelopmental disorders with overlapping features